Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.44 |
| ▸ | CNR2 | P34972 | 8/20 | 0.40 |
| ▸ | CNR1 | P21554 | 7/20 | 0.40 |
| ▸ | SCN5A | Q14524 | 3/20 | 0.40 |
| ▸ | SCN9A | Q15858 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA5A | P35218 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | KIF11 | P52732 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19464361 | 1.00 | CYP1A2 (0.44) | CYP1A2CYP2D6CYP2C19CNR2CNR1 | |
| SCHEMBL20181885 | 0.94 | CYP1A2 (0.42) | CYP1A2CYP2D6CYP2C19CNR2CNR1 | |
| SCHEMBL18737472 | 0.93 | CYP1A2 (0.41) | CYP1A2CYP2D6CYP2C19CNR2CNR1 | |
| SCHEMBL21108598 | 0.90 | CYP1A2 (0.39) | CYP1A2CYP2D6CYP2C19LMNAPOLB | |
| SCHEMBL22692562 | 0.87 | CA1 (0.39) | CYP1A2CYP2D6CYP2C19LMNAPOLB | |
| SCHEMBL26265942 | 0.87 | CNR2 (0.52) | CYP1A2CYP2D6CYP2C19CNR2CNR1 | |
| SCHEMBL27991722 | 0.85 | CNR2 (0.50) | CYP1A2CYP2D6CYP2C19CNR2CNR1 | |
| SCHEMBL10237587 | 0.84 | SCN5A (0.44) | CYP1A2CYP2D6CYP2C19CNR2CNR1 | |
| SCHEMBL16596493 | 0.82 | CYP2D6 (0.43) | CYP1A2CYP2D6CYP2C19CNR2CNR1 | |
| SCHEMBL18994837 | 0.79 | CA1 (0.41) | CYP1A2CYP2D6CYP2C19CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210246115-A1 | ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF | BIOIMICS AB (SE) | 2021-08-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210246115-A1 | ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF | FDPS, FPR1, F12 | CYP1A2 331/4885CYP2D6 220/4885CYP2C19 139/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.